Filice G - Search Results

1

HCV chronic hepatitis in patients with HIV: clinical management issues.

Bruno R, Sacchi P, Puoti M, Soriano V, Filice G. Bruno R, et al. Among authors: filice g. Am J Gastroenterol. 2002 Jul;97(7):1598-606. doi: 10.1111/j.1572-0241.2002.05817.x. Am J Gastroenterol. 2002. PMID: 12135007 Review.

2

Challenges for hepatitis C patients coinfected with HIV.

Bruno R, Cotler S, Sacchi P, Ciappina V, Rondanelli M, Filice G. Bruno R, et al. Among authors: filice g. Am Clin Lab. 2002 Apr;21(3):26-31. Am Clin Lab. 2002. PMID: 12038082 Review. No abstract available.

3

Clinical experiences with interferon as monotherapy or in combination with ribavirin in patients co-infected with HIV and HCV.

Puoti M, Zanini B, Bruno R, Airoldi M, Rossi S, Quiros Roldan E, El Hamad I, Moretti F, Castelli F, Sacchi P, Filice G, Carosi G. Puoti M, et al. Among authors: filice g. HIV Clin Trials. 2002 Jul-Aug;3(4):324-32. doi: 10.1310/TQFQ-VA2X-95AT-H5LM. HIV Clin Trials. 2002. PMID: 12187507 Review.

4

Fast relapse and high drop out rate of 48 weeks daily interferon monotherapy in HIV-infected patients with chronic hepatitis C.

Bruno R, Sacchi P, Puoti M, Ciappina V, Zocchetti C, Brunetti E, Maffezzini E, Capelli A, Patruno SF, Malfitano A, Filice G. Bruno R, et al. Among authors: filice g. BMC Infect Dis. 2002 Aug 28;2:17. doi: 10.1186/1471-2334-2-17. BMC Infect Dis. 2002. PMID: 12199910 Free PMC article. Clinical Trial.

5

Evaluation of the risk factors associated with lipodystrophy development in a cohort of HIV-positive patients.

Seminari E, Tinelli C, Minoli L, Sacchi P, Filice G, Zocchetti C, Meneghetti G, Bruno R, Maserati R. Seminari E, et al. Among authors: filice g. Antivir Ther. 2002 Sep;7(3):175-80. Antivir Ther. 2002. PMID: 12487384

6

Host factors affecting the outcome of treatment of hepatitis C.

Bruno R, Sacchi P, Maiocchi L, Zocchetti C, Filice G. Bruno R, et al. Among authors: filice g. Rev Gastroenterol Disord. 2004;4 Suppl 1:S3-7. Rev Gastroenterol Disord. 2004. PMID: 15184818 Review.

7

Viral dynamics and pharmacokinetics of peginterferon alpha-2a and peginterferon alpha-2b in naive patients with chronic hepatitis c: a randomized, controlled study.

Bruno R, Sacchi P, Ciappina V, Zochetti C, Patruno S, Maiocchi L, Filice G. Bruno R, et al. Among authors: filice g. Antivir Ther. 2004 Aug;9(4):491-7. Antivir Ther. 2004. PMID: 15456079 Clinical Trial.

8

Area-under-the-curve for peginterferon alpha-2a and peginterferon alpha-2b is not related to body weight in treatment-naive patients with chronic hepatitis C.

Bruno R, Sacchi P, Maiocchi L, Zocchetti C, Ciappina V, Patruno S, Filice G. Bruno R, et al. Among authors: filice g. Antivir Ther. 2005;10(2):201-5. Antivir Ther. 2005. PMID: 15865213 Clinical Trial.

9

Hepatotoxicity and nelfinavir: a meta-analysis.

Bruno R, Sacchi P, Maiocchi L, Zocchetti C, Filice G. Bruno R, et al. Among authors: filice g. Clin Gastroenterol Hepatol. 2005 May;3(5):482-8. doi: 10.1016/s1542-3565(05)00162-x. Clin Gastroenterol Hepatol. 2005. PMID: 15880318 Review.

10

Management of hepatocellular carcinoma in human immunodeficiency virus-infected patients.

Bruno R, Puoti M, Sacchi P, Filice C, Carosi G, Filice G. Bruno R, et al. Among authors: filice c, filice g. J Hepatol. 2006;44(1 Suppl):S146-50. doi: 10.1016/j.jhep.2005.11.029. Epub 2005 Dec 1. J Hepatol. 2006. PMID: 16356582 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

270 results

Search Page

Filters